Dalbavancin Hydrochloride News
Dalbavancin Hydrochloride currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Dalbavancin Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Xydalba is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients from birth (see sections 4.4 and 5.1).Consideration should be...
- Evidence level: L5
- Predicted indications (20):
- postinfectious vasculitis (99.8%)
- post-bacterial disorder (99.8%)
- post-infectious syndrome (99.8%)
- infective urethral stricture (99.7%)
- Chagas cardiomyopathy (99.7%)
- infection-related hemolytic uremic syndrome (99.7%)
- otitis externa (99.7%)
- ophthalmic herpes zoster (99.2%)
- skin disease caused by infection (99.2%)
- infectious mononucleosis (99.2%)
- orbital cellulitis (99.0%)
- tinea corporis (98.9%)
- drug-induced osteoporosis (98.7%)
- infectious otitis interna (97.2%)
- ulcerative blepharitis (97.2%)
- parasitic eyelid infestation (97.2%)
- abdominal ectopic pregnancy (96.8%)
- celiac trunk compression syndrome (96.8%)
- abdominal cystic lymphangioma (96.8%)
- lymph node palisaded myofibroblastoma (96.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.